ORIFARM PI A/S: Financial statements 2018
CVR: 27347177
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -169,000 and a net result of DKK 148,979,000 compared with DKK 99,654,000 the year before. Equity in the 2018 report amounted to DKK 502,559,000. The solvency ratio was 89.6%.
- Gross Profit
- DKK -169,000
- Profit/Loss
- DKK 148,979,000
- Equity
- DKK 502,559,000
- Total Assets
- DKK 560,701,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -169K | 149M | 502.6M | - |
| 2017 | - | -174K | 99.7M | 357.5M | - |
| 2016 | - | -203K | 50.1M | 256.8M | - |
| 2015 | - | -27K | 25.3M | 206.2M | - |
| 2014 | - | -30K | 18.7M | 59M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of June 15, 2018, Claus Christian Bayer has left the board of directors of ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2017. Gross profit came to DKK -174,000, and the net result was DKK 99,654,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.